Clonogenic assays in the B16 melanoma: response to cyclophosphamide.

The survival of clonogenic cells in the B16 melanoma has been studied simultaneously by 3 methods: an in vitro assay in soft agar, a lung-colony assay, and the end-point dilution technique. Details of the first 2 methods have previously been reported, but those of the third are described here. The 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Steel, G. G., Adams, K., Stephens, T. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1977
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025400/
https://www.ncbi.nlm.nih.gov/pubmed/588423
_version_ 1782136756079951872
author Steel, G. G.
Adams, K.
Stephens, T. C.
author_facet Steel, G. G.
Adams, K.
Stephens, T. C.
author_sort Steel, G. G.
collection PubMed
description The survival of clonogenic cells in the B16 melanoma has been studied simultaneously by 3 methods: an in vitro assay in soft agar, a lung-colony assay, and the end-point dilution technique. Details of the first 2 methods have previously been reported, but those of the third are described here. The 3 methods have agreed well in investigations of the response of the B16 melanoma to cyclophosphamide.
format Text
id pubmed-2025400
institution National Center for Biotechnology Information
language English
publishDate 1977
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20254002009-09-10 Clonogenic assays in the B16 melanoma: response to cyclophosphamide. Steel, G. G. Adams, K. Stephens, T. C. Br J Cancer Research Article The survival of clonogenic cells in the B16 melanoma has been studied simultaneously by 3 methods: an in vitro assay in soft agar, a lung-colony assay, and the end-point dilution technique. Details of the first 2 methods have previously been reported, but those of the third are described here. The 3 methods have agreed well in investigations of the response of the B16 melanoma to cyclophosphamide. Nature Publishing Group 1977-11 /pmc/articles/PMC2025400/ /pubmed/588423 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Steel, G. G.
Adams, K.
Stephens, T. C.
Clonogenic assays in the B16 melanoma: response to cyclophosphamide.
title Clonogenic assays in the B16 melanoma: response to cyclophosphamide.
title_full Clonogenic assays in the B16 melanoma: response to cyclophosphamide.
title_fullStr Clonogenic assays in the B16 melanoma: response to cyclophosphamide.
title_full_unstemmed Clonogenic assays in the B16 melanoma: response to cyclophosphamide.
title_short Clonogenic assays in the B16 melanoma: response to cyclophosphamide.
title_sort clonogenic assays in the b16 melanoma: response to cyclophosphamide.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025400/
https://www.ncbi.nlm.nih.gov/pubmed/588423
work_keys_str_mv AT steelgg clonogenicassaysintheb16melanomaresponsetocyclophosphamide
AT adamsk clonogenicassaysintheb16melanomaresponsetocyclophosphamide
AT stephenstc clonogenicassaysintheb16melanomaresponsetocyclophosphamide

Ejemplares similares